Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-25 @ 2:59 PM
Study NCT ID:
NCT06737250
Status:
RECRUITING
Last Update Posted:
2024-12-17
First Post:
2024-12-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSL
Sponsor:
NOBO Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-25
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2024-12-06
First Submit QC Date:
None
Study First Post Date:
2024-12-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-11
Last Update Post Date:
2024-12-17
Last Update Post Date Type:
ACTUAL